YMAB YmAbs: Bozor kapitallashuvining balans qiymatiga nisbati

YmAbs (YMAB) - korporativ logo

Y-mAbs Therapeutics (YMAB) yadro markazlari tarmog'i orqali radiofarmatsevtika vositalarining tezkor yetkazib berilishini ta'minlab, yuqori marjalarni saqlab qoladi. Bolalar dori vositalarini tashish paytida haroratning ishonchli nazorati ularning xavfsizligini kafolatlaydi. Brend maqsadli antitanalarni ishlab chiqish bilan mashhur, buni 4.44 ko'rsatkichi tasdiqlaydi. GURU.Markets platformasidagi kompaniyaning bozor tendentsiyasi ushbu ishlab chiqaruvchining aktiv qiymati dinamikasini vizuallashtiradi.

Y-mAbs Therapeutics (YMAB) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 27.09.2025gacha

YMAB (Y-mAbs Therapeutics Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Y-mAbs Therapeutics|YMAB - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi YmAbs|YMAB - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Y-mAbs Therapeutics|YMAB - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati ymabs.com|YMAB - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Y-mAbs Therapeutics|YMAB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati YmAbs|YMAB - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati YmAbs
Fundamental baholash:YMAB (Y-mAbs Therapeutics)
Y-mAbs Therapeutics Inc tayyor mahsulotlari

Y-mAbs Therapeutics (YMAB) eksklyuziv FDA tasdiqlari va kam uchraydigan kasalliklar dori vositalari maqomi tufayli pediatrik onkologiya sohasida monopoliya maqomini saqlab qolmoqda. GURU.Markets platformasidagi joriy bozor qiymati va buxgalteriya qiymati nisbatini tahlil qilish orqali investor aksiyalar qiymatidan yuqori bo'lgan bozor narxi premiumini baholaydi, bu esa kompaniyaning intellektual mulki uchun to'lovning haddan tashqari ko'pligi darajasini va aksiya narxining korreksiyalarga nisbatan umumiy barqarorligini aniqlashga yordam beradi.

Asosiy raqobatchilar

BeiGene Ltd (ONC) - Bozor kapitallashuvining balans qiymatiga nisbati|halozyme.com (HALO) - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati AURA|CADL (Candel Therapeutics, Inc.) - Bozor qiymatining balans qiymatiga koeffitsiyenti|ARAY - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati SELLAS Life Sciences Group Inc. (SLS)|Actuate Therapeutics (ACTU) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Citius Oncology Inc. (CTOR)|TuHURA Biosciences - Bozor kapitallashuvining balans qiymatiga nisbati|TARA - Kapitallashuvning sof aktivlarga nisbati|Fate Therapeutics, Inc. - Kapitallashuvning sof aktivlarga nisbati|WHWK: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati tscan.com TCRX|Champions Oncology, Inc. (CSBR) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati XBIT (XBiotech Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti CEL-SCI Corp (CVM)|OS Therapies Incorporated - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Radiopharm Theranostics Ltd RADX|ARTV (Artiva Biotherapeutics) - Kapitallashuvning sof aktivlarga nisbati|Adlai Nortye Ltd - Bozor qiymatining xususiy kapitalga nisbati|VERU: Bozor qiymatining balans qiymatiga nisbati|TPST - Kapitallashuvning sof aktivlarga nisbati|XLO: Bozor kapitallashuvining balans qiymatiga nisbati|Renovaro (RENB) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Mural Oncology PLC|Bozor qiymatining balans qiymatiga nisbati KAPA|OKUR (OnKure Therapeutics Inc) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi w2.cytomed.sg GDTC|Kapitallashuvning sof aktivlarga nisbati Curis|APLM - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati Tharimmune THAR|ADVB - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati Genprex, Inc GNPX|Calidi Biotherapeutics, Inc. (CLDI) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati SBFM (Sunshine Biopharma)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBIO|Salarius Pharmaceuticals, Inc. (SLRX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Purple Biotech Ltd (PPBT)|Bozor kapitallashuvining balans qiymatiga nisbati AONC (American Oncology Network, Inc.)|BeiGene Ltd - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Checkpoint Therapeutics|ELEV - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ICAD|Bozor qiymatining balans qiymatiga koeffitsiyenti Ikena Oncology|NTBL (Notable Labs Inc.) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Viracta (VIRX)|Kapitallashuvning sof aktivlarga nisbati MorphoSys AG|Bozor kapitallashuvining balans qiymatiga multiplikatori nayabiosciences.com (NAYA)|Bozor kapitallashuvining balans qiymatiga nisbati AAPGV